These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 16023837

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.
    Preclíková H, Bryja V, Pacherník J, Krejcí P, Dvorák P, Hampl A.
    Cell Growth Differ; 2002 Sep; 13(9):421-30. PubMed ID: 12354751
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
    Andrews PW, Damjanov I, Berends J, Kumpf S, Zappavigna V, Mavilio F, Sampath K.
    Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
    [Abstract] [Full Text] [Related]

  • 5. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation.
    Borriello A, Pietra VD, Criscuolo M, Oliva A, Tonini GP, Iolascon A, Zappia V, Ragione FD.
    Oncogene; 2000 Jan 06; 19(1):51-60. PubMed ID: 10644979
    [Abstract] [Full Text] [Related]

  • 6. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
    Wakeman JA, Walsh J, Andrews PW.
    Oncogene; 1998 Jul 16; 17(2):179-86. PubMed ID: 9674702
    [Abstract] [Full Text] [Related]

  • 7. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
    Li R, Faria TN, Boehm M, Nabel EG, Gudas LJ.
    Exp Cell Res; 2004 Mar 10; 294(1):290-300. PubMed ID: 14980522
    [Abstract] [Full Text] [Related]

  • 8. Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: partial retention of a pluripotent phenotype.
    Duran C, Talley PJ, Walsh J, Pigott C, Morton IE, Andrews PW.
    Int J Cancer; 2001 Aug 01; 93(3):324-32. PubMed ID: 11433395
    [Abstract] [Full Text] [Related]

  • 9. Manipulation of human pluripotent embryonal carcinoma stem cells and the development of neural subtypes.
    Stewart R, Christie VB, Przyborski SA.
    Stem Cells; 2003 Aug 01; 21(3):248-56. PubMed ID: 12743319
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid- and bone morphogenetic protein 4-induced apoptosis in P19 embryonal carcinoma cells requires p27.
    Glozak MA, Rogers MB.
    Exp Cell Res; 2001 Aug 15; 268(2):128-38. PubMed ID: 11478839
    [Abstract] [Full Text] [Related]

  • 11. Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting.
    Przyborski SA.
    Stem Cells; 2001 Aug 15; 19(6):500-4. PubMed ID: 11713341
    [Abstract] [Full Text] [Related]

  • 12. Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells.
    Houldsworth J, Heath SC, Bosl GJ, Studer L, Chaganti RS.
    Cell Growth Differ; 2002 Jun 15; 13(6):257-64. PubMed ID: 12114215
    [Abstract] [Full Text] [Related]

  • 13. MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells.
    Sulaiman G, Cooke A, Ffrench B, Gasch C, Abdullai OA, O'Connor K, Elbaruni S, Blackshields G, Spillane C, Keegan H, McEneaney V, Knittel R, Rogers A, Jeffery IB, Doyle B, Bates M, d'Adhemar C, Lee MY, Campbell EL, Moynagh PN, Higgins DG, O'Toole S, O'Neill L, O'Leary JJ, Gallagher MF.
    Cell Death Differ; 2017 Nov 15; 24(11):1975-1986. PubMed ID: 28885616
    [Abstract] [Full Text] [Related]

  • 14. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
    Damjanov I, Horvat B, Gibas Z.
    Lab Invest; 1993 Feb 15; 68(2):220-32. PubMed ID: 7680083
    [Abstract] [Full Text] [Related]

  • 15. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
    Kawazoe S, Ikeda N, Miki K, Shibuya M, Morikawa K, Nakano S, Oshimura M, Hisatome I, Shirayoshi Y.
    Dev Growth Differ; 2009 Feb 15; 51(2):81-93. PubMed ID: 19207180
    [Abstract] [Full Text] [Related]

  • 16. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
    Pera MF, Bennett W, Cerretti DP.
    Lab Invest; 1997 Apr 15; 76(4):497-504. PubMed ID: 9111512
    [Abstract] [Full Text] [Related]

  • 17. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells.
    Matin MM, Walsh JR, Gokhale PJ, Draper JS, Bahrami AR, Morton I, Moore HD, Andrews PW.
    Stem Cells; 2004 Apr 15; 22(5):659-68. PubMed ID: 15342930
    [Abstract] [Full Text] [Related]

  • 18. Abnormal development of mouse embryoid bodies lacking p27Kip1 cell cycle regulator.
    Bryja V, Cajánek L, Pacherník J, Hall AC, Horváth V, Dvorák P, Hampl A.
    Stem Cells; 2005 Aug 15; 23(7):965-74. PubMed ID: 15941856
    [Abstract] [Full Text] [Related]

  • 19. Cell cycle regulation during mouse olfactory neurogenesis.
    Legrier ME, Ducray A, Propper A, Chao M, Kastner A.
    Cell Growth Differ; 2001 Dec 15; 12(12):591-601. PubMed ID: 11751454
    [Abstract] [Full Text] [Related]

  • 20. MAL mRNA is induced during the differentiation of human embryonal carcinoma cells into neurons and is also localised within specific regions of the human brain.
    Wakeman JA, Heath PR, Pearson RC, Andrews PW.
    Differentiation; 1997 Nov 15; 62(2):97-105. PubMed ID: 9404004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.